14 April 2020 2 Min Read
J&J lifts dividend but cuts guidance as pandemic clouds outlook
Johnson & Johnson is the first of the major US health-care company to report earnings and is viewed as a bellwether for the sector
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In